UNRAVELLING THE PHENOTYPE OF CARDIOVASCULAR INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH MAGNETIC RESONANCE IMAGING: THERAPEUTIC BENEFITS OF TNF INHIBITION

UNRAVELLING THE PHENOTYPE OF CARDIOVASCULAR INFLAMMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH MAGNETIC RESONANCE IMAGING: THERAPEUTIC BENEFITS OF TNF INHIBITION

Bibliographic Details
Main Authors:	Puntmann, V, Taylor, P, Barr, A, Chiribiri, A, Nagel, E
Format:	Journal article
Published:	2011

Similar Items

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1995)

TNF alpha as a therapeutic target in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)

20th anniversary of TNF inhibitors in rheumatoid arthritis
by: Taylor, P
Published: (2019)

Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study.
by: Puntmann, V, et al.
Published: (2010)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
by: Feldmann, M, et al.
Published: (2011)

Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
by: Taylor, P
Published: (2001)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
by: Maini, R, et al.
Published: (1993)

Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
by: Thivya Balendran, et al.
Published: (2023-06-01)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
by: Feldmann, M
Published: (1996)

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
by: Feldmann, M, et al.
Published: (2003)

Coupling vascular and myocardial inflammatory injury into a common phenotype of cardiovascular dysfunction: systemic inflammation and aging - a mini-review.
by: Puntmann, V, et al.
Published: (2011)

Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
by: Taylor, P
Published: (2010)

Reduction of cardiovascular risk in rheumatoid arthritis: double benefit of statins
by: Diana Sergeevna Novikova, et al.
Published: (2010-12-01)

Development of anti-TNF therapy for rheumatoid arthritis.
by: Feldmann, M
Published: (2002)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1994)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2009)

Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: Preclinical and clinical studies
by: Feldmann, M, et al.
Published: (2002)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
by: Feldmann, M, et al.
Published: (2002)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
by: Taylor, P, et al.
Published: (2000)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
by: E. A. Golikova, et al.
Published: (2012-05-01)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
by: Gaelle Vial, et al.
Published: (2021-01-01)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
by: Maini, R, et al.
Published: (2000)

TNF alpha--a pivotal role in rheumatoid arthritis?
by: Brennan, F, et al.
Published: (1992)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
by: Maini, R, et al.
Published: (1997)

The association of extended TNF haplotypes and susceptibility to rheumatoid arthritis
by: Newton, J, et al.
Published: (2001)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (2001)

TNFα - A pivotal role in rheumatoid arthritis?
by: Brennan, F, et al.
Published: (1992)

The metabolic effects of TNF inhibitors in rheumatoid arthritis patients
by: Alexandra Jitaru, et al.
Published: (2019-12-01)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
by: Anne Mirjam Kerola, et al.
Published: (2021-05-01)

Molecular therapeutic targets in rheumatoid arthritis.
by: Sacre, S, et al.
Published: (2005)

Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.
by: Full, L, et al.
Published: (2011)

Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets
by: Taylor, P, et al.
Published: (2004)

Complement factor H attenuates TNF-α-induced inflammation by upregulating EIF3C in rheumatoid arthritis
by: Yimeng Jia, et al.
Published: (2023-11-01)

The effect of TNF blockade on insulin resistance in patients with rheumatoid arthritis
by: Edwards, C, et al.
Published: (2006)

Citrullination of autoantigens: upstream of TNFα in the pathogenesis of rheumatoid arthritis.
by: Quirke, A, et al.
Published: (2011)

Metabolic Effects of Anti-TNF-α Treatment in Rheumatoid Arthritis
by: Kristína Macáková, et al.
Published: (2023-11-01)

Rheumatoid arthritis: influence of inflammation and anti-inflammatory therapy on cardiovascular risk factors
by: D. I. Trukhan, et al.
Published: (2020-08-01)

Rheumatoid arthritis and cardiovascular pathology
by: Saule Abisheva, et al.
Published: (2018-04-01)

Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
by: Xuefei Li, et al.
Published: (2023-10-01)

Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients
by: Ntusi, N, et al.
Published: (2018)